European Sovereignty Monitor

Industry, investment and R&D

Owkin licenses K Pro AI scientist and patient data to Servier for oncology research

Owkin, the Paris based AI biotech, licensed its K Pro AI Scientist platform and multimodal patient data from its MOSAIC network to French drugmaker Servier, extending an existing oncology research partnership. No financial terms were disclosed.

Verified AI-drafted Owkin press release, 11 September 2026

What it does not test. Does not disclose deal value, exclusivity terms, or any change in data ownership, infrastructure control or supply chain dependency between the two firms.

How this item counts. No movement: no answer to who owns, who operates, whose law governs or who made the parts changes. Weight 0. licensing deal between two French firms; no change in own/operate/law/parts disclosed. European Sovereignty Index

How this item was made. Drafted by an AI system (Claude (Anthropic)) from the source cited above and published under the editor’s responsibility without a person reading it first. How the record is made

Previously in Industry, investment and R&D

VerifiedAI-drafted Commission report: EU needs EUR 560 billion more R&D investment to hit 2030 target VerifiedAI-drafted Commission adds EUR 210 million to Marie Sklodowska Curie Actions for researchers ReportedAI-drafted VC firm Headline closes USD 400 million fund for European AI founders

All Industry, investment and R&D news →